These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12463140)

  • 41. [Treatment of metastatic kidney cancer in elderly subjects].
    Escudier B; Paparel P; Neuzillet Y; Long JA; Rioux-Leclercq N; Correas JM; Lang H; Poissonnier L; Baumert H; Mejean A; Patard JJ
    Prog Urol; 2009 Nov; 19 Suppl 3():S129-32. PubMed ID: 20123496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Course of pulmonary metastases from kidney cancer treated by chemotherapy].
    Thomas JP; Timbal Y; Garreta L; Debonnière C; Serrault M
    J Urol Nephrol (Paris); 1974; 80(1):136-40. PubMed ID: 4841732
    [No Abstract]   [Full Text] [Related]  

  • 43. Renal cancer treatment: a review of the literature.
    Gattinoni L; Alù M; Ferrari L; Nova P; Del Vecchio M; Procopio G; Laudani A; Agostara B; Bajetta E
    Tumori; 2003; 89(5):476-84. PubMed ID: 14870767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunotherapy study in the treatment of metastatic renal cancer in the adult].
    Philip T; Negrier S
    Bull Acad Natl Med; 1992 Jun; 176(6):873-7; discussion 877-8. PubMed ID: 1464033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Status of adjuvant therapy for renal cell cancer.
    Sagalowsky A; Donohue J
    J Indiana State Med Assoc; 1979 Jul; 72(7):521-4. PubMed ID: 383849
    [No Abstract]   [Full Text] [Related]  

  • 46. [New anti-angiogenic strategies in the management of kidney cancer].
    Drai J; Pignot G; Bessede T; Boulière F; Hammoudi Y; Ferlicot S; Patard JJ
    Prog Urol; 2013 Sep; 23(10):841-8. PubMed ID: 24034795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kidney cancer.
    Vogelzang NJ; Stadler WM
    Lancet; 1998 Nov; 352(9141):1691-6. PubMed ID: 9853456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Limits of surgery in kidney cancer with metastases].
    Grasset D; Navratil H; Navas P
    J Urol Nephrol (Paris); 1974; 80(1):175-6. PubMed ID: 4841740
    [No Abstract]   [Full Text] [Related]  

  • 49. [Proceedings: Value of progesterone in metastases of kidney cancer].
    Bracci U
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):404. PubMed ID: 4804408
    [No Abstract]   [Full Text] [Related]  

  • 50. [Possibilities and limits in the therapy of metastatic hypernephroid carcinoma].
    Leisering W; Reichel J; Siegmund B
    Z Arztl Fortbild (Jena); 1980 Jun; 74(11):525-8. PubMed ID: 7467424
    [No Abstract]   [Full Text] [Related]  

  • 51. [On kidney neoplasms].
    Bergmann M; Lipsky H
    Chirurg; 1968 Jan; 39(1):32-6. PubMed ID: 5665283
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of metastatic renal cancer in adults with elliptinium acetate].
    Amiel JL; Rouessé J; Droz JP; Caille P; Travagli JP; Théodore C; Le Chevalier T; Ducret JP; Bidart M; Garnier HS
    Presse Med; 1984 Jun; 13(25):1555-7. PubMed ID: 6234539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient characteristics and treatments one year after diagnosis of renal cancer in 2015 according to the presence or absence of metastasis and a history of another tumour: A national observational study.
    Tuppin P; Paita M; Gastaldi-Menager C; Le Bihan-Benjamin C; Jean Bousquet P; Fagot Campagna A
    Bull Cancer; 2019 Jun; 106(6):538-549. PubMed ID: 31072597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [On the medical treatment of metastases of hypernephroid cancer of the kidneys].
    Evseenko LS; Orlova RS; Barsel' VA; Disvetova VV
    Vopr Onkol; 1966; 12(9):53-5. PubMed ID: 6004069
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of malignant tumors of the kidney in children].
    Schweisguth O; Schlienger M; Lemerle J
    Cah Coll Med Hop Paris; 1967; 8(9):801-6. PubMed ID: 5619605
    [No Abstract]   [Full Text] [Related]  

  • 56. CLINICAL EXPERIENCES WITH THALIDOMIDE IN PATIENTS WITH CANCER.
    GRABSTALD H; GOLBEY R
    Clin Pharmacol Ther; 1965; 6():298-302. PubMed ID: 14296026
    [No Abstract]   [Full Text] [Related]  

  • 57. Interferon and kidney cancer: a promise unfulfilled?
    Naitoh J; Belldegrun AS
    Cancer J Sci Am; 1998; 4(3):155-6. PubMed ID: 9612594
    [No Abstract]   [Full Text] [Related]  

  • 58. Combination therapy for advanced and metastatic kidney cancer.
    Lee CH; Motzer RJ
    Nat Rev Urol; 2019 Feb; 16(2):77-78. PubMed ID: 30538301
    [No Abstract]   [Full Text] [Related]  

  • 59. Predictive value of inflammatory indexes on the chemotherapeutic response in patients with unresectable lung cancer: A retrospective study.
    Sun H; Hu P; Du J; Wang X
    Oncol Lett; 2018 Mar; 15(3):4017-4025. PubMed ID: 29467910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
    Sun H; Hu P; Shen H; Dong W; Zhang T; Liu Q; Du J
    PLoS One; 2015; 10(12):e0144663. PubMed ID: 26656866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.